| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Assertio Holdings, Inc. | Director | Common Stock | 151,159 | $167,786 | $1.11 | 11 Jun 2024 | Direct |
| Assertio Holdings, Inc. | Director | Stock Option (right to buy) | 81,225 | 23 May 2024 | Direct | ||
| Caris Life Sciences, Inc. | Director | Common Stock | 16,129 | 17 Jun 2025 | Direct | ||
| SPECTRUM PHARMACEUTICALS INC | Director | Common Stock, $0.001 par value | 0 | $1.10 | 31 Jul 2023 | Direct | |
| SPECTRUM PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | 31 Jul 2023 | Direct |